• Home
  • About
  • Stock Information
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Backgrounders
  • Images
  • Technology
  • Pipeline
  • Partnering
  • Privacy Policy
  • Terms and Conditions of Use
  • Newsletters
  • Technology

    Agenus has been committed to the field of immuno-oncology for the past 20 years. In the past several years we have expanded our capabilities by adding state of the art platforms and technologies to enable us to discover, develop, and manufacture key technologies. These include a series of strategic transactions to expand scientific and technological capabilities as well as collaborations with corporate, academic and clinical entities. We are positioned to discover and develop a broad range of innovative therapeutic antibodies and vaccines through our focused efforts to assemble a uniquely comprehensive arsenal of complementary technologies.

    we have the ability to discover a broad range of innovative antibodies and vaccines internally